How to Get CagriSema Online in Poland
CagriSema is a highly anticipated weight-loss medication currently in clinical trials. It is not yet approved for prescription in the EU, including Poland, and Hi-Doctor does not offer it.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
Many patients in Poland are searching for advanced weight-loss solutions like CagriSema online. However, it's important to understand that CagriSema is currently not approved for weight-loss prescription anywhere in the European Union, including Poland, as it is still undergoing clinical trials. Therefore, Hi-Doctor does not currently offer CagriSema. Here's what CagriSema actually is, why it isn't a normal option yet, and what proven, EU-approved weight-loss medications you can get today from an EU-licensed doctor.
What is CagriSema, and why isn't it a normal option yet?
CagriSema is an investigational drug developed by Novo Nordisk, combining two active ingredients: semaglutide (a GLP-1 receptor agonist, like in Ozempic and Wegovy) and cagrilintide (an amylin analogue). This combination aims to provide a more comprehensive approach to weight loss by targeting multiple pathways that regulate appetite and metabolism. While clinical trials have shown promising results, CagriSema has not yet received regulatory approval from the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for widespread use. This means it is not legally available for prescription, and any online sources claiming to sell it are likely unregulated or counterfeit, posing significant health risks. Accessing medication without a valid prescription from a licensed doctor is unsafe and ill-advised.
Proven weight-loss medications available online today
While CagriSema is not yet available, several highly effective and EMA-approved weight-loss medications are accessible through Hi-Doctor's EU-licensed medical professionals:
- Ozempic (semaglutide): Primarily approved for type 2 diabetes, doctors may prescribe it off-label for weight management when appropriate, following a thorough medical evaluation.
- Wegovy (semaglutide): This is a higher-dose formulation of semaglutide specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
- Mounjaro (tirzepatide): A GIP and GLP-1 receptor agonist, Mounjaro is approved for type 2 diabetes and is also gaining recognition for its significant weight-loss benefits, with specific weight-loss indications expected soon.
- Saxenda (liraglutide): Another GLP-1 receptor agonist, Saxenda is approved for chronic weight management and is administered daily.
An EU-licensed doctor will assess your health profile and recommend the most suitable and safest treatment for your individual needs.
How to get a weight-loss prescription online in Poland
Hi-Doctor offers a straightforward, safe, and fully regulated path to obtaining an EU-valid prescription for approved weight-loss medications, accepted in Poland and across the EU:
- Complete an online questionnaire: Spend 2-3 minutes providing your medical history and current health status through our secure platform.
- EU-licensed doctor reviews your case: An experienced EU-licensed doctor will carefully evaluate your information to determine if an online prescription is medically appropriate for you.
- REMPE prescription in <24 h if appropriate: If approved, you'll receive a valid REMPE electronic prescription (Spanish standard, valid EU-wide) within 24 hours. The €25 consultation fee is refunded automatically if the doctor finds treatment inappropriate for you.
- Pick up at any EU pharmacy: Download your prescription as a PDF from your private account or email. You can then present it at any pharmacy in Poland or any other EU country, thanks to cross-border prescription directive 2011/24/EU.
Why choose Hi-Doctor over unregulated peptide sellers
Choosing Hi-Doctor ensures your safety and access to legitimate, high-quality medical care. Unlike unregulated 'research chemical' or grey-market peptide vendors, Hi-Doctor provides:
- EU-licensed doctors: All consultations are conducted by qualified medical professionals licensed within the EU.
- Real medications, real pharmacies: Prescriptions are for genuine, approved medications dispensed by any legitimate EU pharmacy, ensuring traceability and quality.
- Auditable, RGPD-compliant chat: All communications are secure and comply with strict EU data protection regulations.
- Proven track record: With over 50,000 patients served and a 4.8-star rating on Trustpilot, Hi-Doctor is a trusted name in online healthcare.
Avoid the significant risks associated with unverified online sellers and unknown substances; your health is too important.
COMMON QUESTIONS
Frequently asked questions
No, CagriSema is not yet approved by the EMA, making it illegal to buy or sell as a prescription medication in Poland or any EU country. Any online offers are likely for unapproved or counterfeit products.
